about
Role of MicroRNA miR-27a and miR-451 in the regulation of MDR1/P-glycoprotein expression in human cancer cellsPseudoxanthoma elasticum: a clinical, pathophysiological and genetic update including 11 novel ABCC6 mutationsRecent insights in nanotechnology-based drugs and formulations designed for effective anti-cancer therapyEmerging Role of miRNAs in the Drug Resistance of Gastric CancerNew Findings on Breast Cancer Stem Cells: A ReviewCaveolin-1, a stress-related oncotarget, in drug resistanceExploiting nanotechnology to overcome tumor drug resistance: Challenges and opportunitiesOvercoming drug efflux-based multidrug resistance in cancer with nanotechnologyPharmacogenetic profiling in patients with advanced colorectal cancer treated with first-line FOLFIRI chemotherapy.Chemoresistance and targeted therapies in ovarian and endometrial cancersPlausible Drug Targets in the Streptococcus mutans Quorum Sensing Pathways to Combat Dental Biofilms and Associated RisksDrug transporters in tissues and cells relevant to sexual transmission of HIV: Implications for drug deliveryTowards a targeted multi-drug delivery approach to improve therapeutic efficacy in breast cancerOptimized purification of a heterodimeric ABC transporter in a highly stable form amenable to 2-D crystallizationSensitive and specific fluorescent probes for functional analysis of the three major types of mammalian ABC transportersPrediction of promiscuous p-glycoprotein inhibition using a novel machine learning schemeBIRB796, the inhibitor of p38 mitogen-activated protein kinase, enhances the efficacy of chemotherapeutic agents in ABCB1 overexpression cellsChanges in the expression of miR-381 and miR-495 are inversely associated with the expression of the MDR1 gene and development of multi-drug resistanceThe strong in vivo anti-tumor effect of the UIC2 monoclonal antibody is the combined result of Pgp inhibition and antibody dependent cell-mediated cytotoxicityHuman mesenchymal stem cells are resistant to Paclitaxel by adopting a non-proliferative fibroblastic stateMiR-130a and MiR-374a Function as Novel Regulators of Cisplatin Resistance in Human Ovarian Cancer A2780 CellsABCA2 is a marker of neural progenitors and neuronal subsets in the adult rodent brainNeoadjuvant chemotherapy induces expression levels of breast cancer resistance protein that predict disease-free survival in breast cancerTargeting multidrug resistance in cancerMeta-analytic support vector machine for integrating multiple omics data.Multiple drugbinding sites on the R482G isoform of the ABCG2 transporter.Molecular models of human P-glycoprotein in two different catalytic statesModulation of a Schistosoma mansoni multidrug transporter by the antischistosomal drug praziquantel.Design, synthesis, and biological evaluations of 2,5-diaryl-2,3-dihydro-1,3,4-oxadiazoline analogs of combretastatin-A4.Trastuzumab emtansine: mechanisms of action and drug resistanceMarkers of tumor-initiating cells predict chemoresistance in breast cancer.Asymmetric ATP hydrolysis cycle of the heterodimeric multidrug ABC transport complex TmrAB from Thermus thermophilus.Uncaria alkaloids reverse ABCB1-mediated cancer multidrug resistance.Estradiol induces export of sphingosine 1-phosphate from breast cancer cells via ABCC1 and ABCG2.Direct assessment of P-glycoprotein efflux to determine tumor response to chemotherapy.Evaluating the response of neoadjuvant chemotherapy for treatment of breast cancer: are tumor biomarkers and dynamic contrast enhanced MR images useful predictive tools?Expression of ATP7B in human gastric cardiac carcinomas in comparison with distal gastric carcinomas.The design and discovery of water soluble 4-substituted-2,6-dimethylfuro[2,3-d]pyrimidines as multitargeted receptor tyrosine kinase inhibitors and microtubule targeting antitumor agentsDrug resistance in brain diseases and the role of drug efflux transporters.P-Glycoprotein/MDR1 regulates pokemon gene transcription through p53 expression in human breast cancer cells
P2860
Q24647234-53B75271-7D0E-4B83-89C1-89BC3A003A79Q24674089-37184289-AB31-42C5-8563-E7E3077FB0DFQ26745710-DC455290-7F7A-44CD-AB32-71D030FDA15BQ26752006-1F8D4E46-1DC4-4A48-840D-0012BFABA043Q26771894-38543395-1E77-4FDF-8957-4903CD96F6FCQ26782615-7D6F3BBF-2112-4E7C-A448-A53234B526A6Q26828930-E9F49D7A-2825-46CA-AF5B-BFD5953333C3Q26849264-CD7140FA-BB5C-488E-B3B3-3DD99D98426BQ27863360-DC5E0713-2C5E-4430-AC07-A1252E9BD4FDQ28073246-6E1C7066-42E3-4E50-95B3-DBFEBEC1FA61Q28080935-65B40F6C-C202-4275-BCA0-E59ADFD710D9Q28081272-87082E7F-9437-4686-8F50-86B75EDF4465Q28291499-FDA089B5-742D-46C6-A1BD-753D9F8FED61Q28478129-48F481E4-1E88-4997-8216-FD7E1071E064Q28479253-197609FD-AF04-45A0-8C1E-73A2A91626E1Q28481547-25E21F16-DD63-472D-A558-789D9FEC51A5Q28485188-8719115D-143A-4FE1-B586-4450EB0A1455Q28535423-71109758-95B7-4B63-9B39-8F993C26B4F6Q28543104-D3B7704D-33DE-4865-9F49-3E6974C2D068Q28547691-225B5954-72A8-4EE0-BEFD-4CB0148ADF30Q28547840-322F8EC5-4B1A-4BD6-8740-BDA29534AE58Q28578255-FB0A32B4-28AD-422F-BCA5-E73C8901BB72Q28706276-3EF15EFB-2878-4EC6-9871-3DA2A8663117Q29616803-55FF2831-FAD9-4D92-9FA4-A177505C8322Q31158830-5F91F25B-2883-4806-AC4D-2ADE4922993DQ33257856-6E6A859F-8F46-460C-86A6-AE2B7E7EBBC8Q33401731-ACF20427-8040-4C40-9B4A-631ED99ECED5Q33552868-1021AAAE-2F3B-4679-B32D-B0D9F1C2636DQ33606508-572C64B1-A049-4813-B7AB-D2B25B354464Q33759627-59CAD061-6278-45AC-B059-19AFF97BCDE9Q33781163-ADB4E2A0-4AED-4B62-9D80-E73F62EBC735Q33781872-AFC18A62-3507-499A-B75B-9D8D958F776EQ33788000-28AAFBB7-2611-47DF-B881-50C34ACB4BC5Q33796082-9B2B5EC0-0409-43DA-AAAB-B7CEA8901E8EQ33814552-943720D2-7F54-4FC1-ADF9-7527DC8F6823Q33814616-80DEAD8D-9CDC-424F-81A0-D83E6E5EAB0EQ33868777-D99590C9-9F8D-496E-83EC-259A9C90D9B8Q33872751-5A7C8703-C72F-442D-B29C-D4570C5206BCQ33988704-9AA4C29D-3C3E-4A2F-85FA-C5A837538887Q34205543-A71A8C1E-2C74-4100-B000-916C6A9FDB23
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
The role of ABC transporters in clinical practice.
@ast
The role of ABC transporters in clinical practice.
@en
The role of ABC transporters in clinical practice.
@nl
type
label
The role of ABC transporters in clinical practice.
@ast
The role of ABC transporters in clinical practice.
@en
The role of ABC transporters in clinical practice.
@nl
prefLabel
The role of ABC transporters in clinical practice.
@ast
The role of ABC transporters in clinical practice.
@en
The role of ABC transporters in clinical practice.
@nl
P2093
P1433
P1476
The role of ABC transporters in clinical practice.
@en
P2093
Gregory D Leonard
Susan E Bates
P304
P356
10.1634/THEONCOLOGIST.8-5-411
P577
2003-01-01T00:00:00Z